compounded semaglutide being discontinued Discontinued? Current Status Compounded Semaglutide Injection: GLP-1 weight

Remember, weight loss is a gradual process, and with expert support and resources, you can successfully reach your goals

You can schedule a consultation directly with an obesity specialist or weight management provider

The review contextualised native GLP-1 as the reference molecule for the entire dual GIP/GLP-1 receptor agonist research field including tirzepatide (approved) and novel triple agonists targeting GLP-1R, GIPR, and GCGR simultaneously confirming native GLP-1s ongoing research importance as the pharmacological anchor of this rapidly expanding compound class

Both cagrilintide and retatrutide are administered as subcutaneous injections , typically once weekly